Patent Yard Sign in
Expired Canadian patentCanada

Quinoline ether alkanoic acids for use as inhibitors of leukotriene biosynthesis

CA 1333714 C · Owner: Merck Frosst Canada Incorporated · Inventors: Young, Robert N.; Prasit, Petpiboon; Zamboni, Robert

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Compounds having the formula:, I, are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating diarrhea, hypertension angina, platelet aggregation, cerebral spasm prema-, ture labor, spontaneous abortion dysmenorrhea, and, migraine.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted December 27, 1994. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended December 27, 2011.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 23, 1989
GrantedDecember 27, 1994
Term endedDecember 27, 2011
Patent numberCA 1333714 C
Classification (IPC)C07D215/14 +2 more

Timeline

Timeline From CIPO dates

19901993199619992002200520082011Application filedJune 23, 1989Patent grantedDec 27, 1994Term endedDec 27, 2011

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.